Reuters logo
BRIEF-Adamas announces FDA approval of Gocovri as first and only medication for dyskinesia treatment in Parkinson’s disease patients
2017年8月24日 / 晚上8点40分 / 1 个月前

BRIEF-Adamas announces FDA approval of Gocovri as first and only medication for dyskinesia treatment in Parkinson’s disease patients

Aug 24 (Reuters) - Adamas Pharmaceuticals Inc

* Adamas Pharmaceuticals Inc - ‍Gocovri is expected to be available in Q4, and formally launched in Jan 2018​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below